 |
| 22-Apr-13 | Downgrade |
Feltl & Co. |
Strong Buy → Buy |
|
|
| 12-Apr-13 | Downgrade |
Stifel |
Buy → Hold |
|
|
| 01-Feb-13 | Upgrade |
Feltl & Co. |
Buy → Strong Buy |
$41.50 → $49 |
|
| 08-Nov-12 | Initiated |
Stifel Nicolaus |
Buy |
$44 |
|
| 06-Jan-12 | Initiated |
Feltl & Co. |
Buy |
$34.25 |
|
| 06-Jan-12 | Initiated |
Canaccord Genuity |
Hold |
$30 |
|
| 20-Jul-10 | Upgrade |
Avondale |
Mkt Perform → Mkt Outperform |
$27 |
|
| 24-Mar-10 | Initiated |
Avondale |
Mkt Perform |
$27 |
|
| 11-Feb-10 | Upgrade |
Sun Trust Rbsn Humphrey |
Neutral → Buy |
$30 |
|
| 13-Oct-09 | Downgrade |
Sun Trust Rbsn Humphrey |
Buy → Neutral |
|
|
| 10-Mar-09 | Upgrade |
Sun Trust Rbsn Humphrey |
Neutral → Buy |
$21 |
|
| 28-Oct-08 | Reiterated |
CL King |
Strong Buy |
$39 → $26 |
|
| 19-Aug-08 | Initiated |
Piper Jaffray |
Neutral |
|
|
| 25-Jul-08 | Downgrade |
Sun Trust Rbsn Humphrey |
Buy → Neutral |
|
|
| 19-Mar-08 | Initiated |
Jesup & Lamont |
Neutral |
$27 |
|
| 01-Feb-08 | Reiterated |
Northland Securities |
Market Perform |
$38 → $33 |
|
| 15-Jan-08 | Initiated |
Northland Securities |
Market Perform |
|
|
| 10-Dec-07 | Reiterated |
Sun Trust Rbsn Humphrey |
Buy |
$28 → $42 |
|
| 07-Nov-07 | Reiterated |
CL King |
Strong Buy |
$30 → $39 |
|
| 25-Oct-07 | Reiterated |
CL King |
Strong Buy |
$26 → $30 |
|
|
|
| 21-May-13 08:00AM | Abaxis, Inc. to Present at the Stifel Annual Dental & Veterinary Conference PR Newswire |
| 08-May-13 08:00AM | Abaxis, Inc. to Present at the Bank of America Merrill Lynch 2013 Health Care Conference PR Newswire |
| 30-Apr-13 07:09AM | ABAXIS INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online |
| 07:09AM | ABAXIS INC Files SEC form 8-K, Change in Directors or Principal Officers at Reuters |
| 28-Apr-13 11:49AM | 3 Healthcare Stock Winners and 2 Losers After Earnings Are Digested at Wall St. Cheat Sheet |
| 26-Apr-13 03:20PM | Earnings Beat for ABAX, Sluggish Overall Zacks -7.29% |
| 12:02PM | Oversold Conditions For Abaxis (ABAX) at TheStreet |
| 25-Apr-13 09:53PM | ABAXIS CEO Discusses Q4 2013 Results - Earnings Call Transcript at Seeking Alpha |
| 07:04PM | Abaxis Earnings: Heres Why Investors are Ambivalent Now at Wall St. Cheat Sheet |
| 04:21PM | InPlay: Abaxis beats by $0.04, misses on revs Briefing.com |
| 04:00PM | Abaxis Reports Financial Performance For The Fourth Quarter And Fiscal 2013 PR Newswire |
| 09:04AM | ABAXIS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online |
| 09:04AM | ABAXIS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits at Reuters |
| 07:07AM | Q4 2013 ABAXIS INC Earnings Release - After Market Close CCBN |
| 07:07AM | Q4 2013 ABAXIS INC Earnings Release - After Market Close at Reuters |
| 22-Apr-13 02:43AM | Abaxis downgraded by Feltl & Co. Briefing.com |
| 02:43AM | Abaxis downgraded by Feltl & Co. at Reuters |
| 17-Apr-13 08:00AM | Abaxis To Report Fourth Quarter And Fiscal Year 2013 Financial Results Thursday, April 25, 2013 PR Newswire |
| 12-Apr-13 03:15PM | BP Gets Booed and 2 More Analysts Downgrades To Know at Wall St. Cheat Sheet -5.12% |
| 02:11PM | Abaxis slips from highs as analyst cuts rating AP |
| 01:10AM | Abaxis downgraded by Stifel Briefing.com |
| 08-Apr-13 05:07PM | SEC settles with woman whose brother sent her tips to SAC manager at Reuters |
| 04:12PM | Ex-Abaxis Employee Will Pay $145,000 in SEC Expert Network Case at Bloomberg |
| 01-Apr-13 02:28PM | Abaxis Pinned at Neutral Zacks |
| 28-Mar-13 02:08PM | QIAGEN Extends Portfolio Zacks |
| 25-Mar-13 04:45PM | St. Jude Prices Senior Notes Zacks |
| 02:28PM | HOLX to Feature Innovative Products Zacks |
| 01:58PM | Hologic Offloads LIFECODES Biz Zacks |
| 22-Mar-13 05:38PM | Hanger Stays Neutral Zacks |
| 19-Mar-13 12:58PM | Pediatric Exclusivity for Hospira's Drug Zacks |
| 11:58AM | Stryker Launches Iconix Zacks |
| 18-Mar-13 04:54PM | Plethora of Positive Data for GHDX Zacks |
| 15-Mar-13 11:00AM | Wall Street Transcript Interview with Steven Quay, CEO of Atossa Genetics, Inc. (ATOS) Wall Street Transcript |
| 09:31AM | NY judge gives prison to exec for insider scheme AP |
| 12:01AM | SAC Fund Managers Tipper Nguyen Gets One Year in Prison at Bloomberg |
| 14-Mar-13 06:14PM | Ex-research firm executive sentenced for insider trading Reuters |
| 06:06PM | Ex-research firm executive sentenced for insider trading at Reuters |
| 05:18PM | Another Primary Global Expert Sentenced to Prison for Insider Trading at Forbes |
| 04:48PM | SAC Fund Managers Tipper Nguyen Gets One Year in Prison at Bloomberg |
| 02:28PM | Excerpts from Medtronic's Confab Zacks |
| 12-Mar-13 02:28PM | St. Jude's ILUMIEN OPTIS Now in Japan Zacks |
| 11-Mar-13 01:49PM | Wall Street Mixed In Afternoon; Abaxis Hits New High at Investor's Business Daily |
| 08:00AM | Abaxis, Inc. to Present at the Sidoti & Company Seventeenth Annual Institutional Investor Forum PR Newswire |
| 08-Mar-13 01:30PM | Stocks Up In Afternoon; Cooper, Abaxis At New Highs at Investor's Business Daily |
| 27-Feb-13 10:00AM | On The Fly: Analyst Downgrade Summary theflyonthewall.com |
| 25-Feb-13 10:11AM | On The Fly: Analyst Downgrade Summary theflyonthewall.com |
| 08:00AM | Abaxis, Inc. to Present at the Raymond James 34th Annual Institutional Investor Conference PR Newswire |
| 19-Feb-13 07:58AM | Alere Beats in 4Q, Reduces Loss Zacks |
| 15-Feb-13 01:04PM | ABAXIS INC Financials EDGAR Online Financials |
| 08:00AM | Abaxis to Present at Lazard Capital Markets 5th Annual Medical Technology Snowbird Conference PR Newswire |
| 12-Feb-13 01:48PM | Epocal Acquired by Alere Zacks |
| 11-Feb-13 03:04PM | ABAXIS INC Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 04-Feb-13 01:19PM | Nasdaq stocks posting largest percentage increases AP |
| 02-Feb-13 06:52PM | New Star Analyst Rankings for ABAXIS, Inc. StarMine |
| 01-Feb-13 06:02PM | Nasdaq stocks posting largest percentage increases AP +14.39% |
| 02:08PM | Abaxis Surpasses Estimates in 3Q Zacks |
| 01:18PM | Nasdaq stocks posting largest percentage increases AP |
| 12:03PM | Why Abaxis Shares Jumped at Motley Fool |
| 01:19AM | Abaxis upgraded by Feltl & Co. Briefing.com |
| 31-Jan-13 11:16PM | Abaxis' CEO Discusses Q3 2013 Results - Earnings Call Transcript at Seeking Alpha |
| 09:06PM | Abaxis Beats on Both Top and Bottom Lines at Motley Fool |
| 04:06PM | ABAXIS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online |
| 04:02PM | InPlay: Abaxis beats by $0.02, beats on revs Briefing.com |
| 04:00PM | Abaxis Reports Record Revenues For The Third Quarter Of Fiscal 2013 PR Newswire |
| 07:07AM | Q3 2013 ABAXIS INC Earnings Release - After Market Close CCBN |
| 30-Jan-13 09:45AM | BMRA: Initiating at Outperform Zacks Small Cap Research |
| 23-Jan-13 08:00AM | Abaxis To Report Third Quarter Fiscal Year 2013 Financial Results Thursday, January 31, 2013 PR Newswire |
| 21-Jan-13 09:08AM | Will Abaxis Beat These Analyst Estimates? at Motley Fool |
| 27-Dec-12 12:30PM | Regeneron Pharmaceuticals and Other Healthcare Stocks Making Big Moves on December 27, 2012 at Investopedia |
| 07-Dec-12 06:02AM | ABAXIS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online |
| 06-Dec-12 05:41PM | InPlay from Briefing.com Briefing.com |
| 05:24PM | InPlay: Abaxis announces special cash dividend of $1.00 per share Briefing.com |
| 05:22PM | Abaxis Declares Special Cash Dividend of $1.00 Per Share PR Newswire |
| 30-Nov-12 08:56PM | Insight: Lawyers gain from "say-on-pay" suits targeting U.S. firms at Reuters |
| 06:59AM | RPT-INSIGHT-Lawyers gain from 'say-on-pay' suits targeting US firms at Reuters |
| 01:10AM | Insight: Lawyers gain from "say-on-pay" suits targeting U.S. firms at Reuters |
| 12:59AM | INSIGHT-Lawyers gain from 'say-on-pay' suits targeting US firms at Reuters |
| 29-Nov-12 01:10AM | Don't Get Too Worked Up Over Abaxis's Earnings at Motley Fool |
| 27-Nov-12 06:48PM | Abaxis: Buy The Market's Oversight at Seeking Alpha |
| 20-Nov-12 08:00AM | Abaxis, Inc. to Present at 24th Annual Piper Jaffray Healthcare Conference PR Newswire |
| 15-Nov-12 01:04PM | ABAXIS INC Financials EDGAR Online Financials |
| 14-Nov-12 08:49AM | Alere Tops Estimates in 3Q Zacks |
| 13-Nov-12 05:30PM | ABAXIS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Other Events EDGAR Online |
| 08:00AM | Abaxis, Inc. to Participate in Sidoti & Company's Inaugural One-on-One Conference PR Newswire |
| 12-Nov-12 10:00AM | On The Fly: Analyst Initiation Summary theflyonthewall.com |
| 09-Nov-12 04:52PM | ABAXIS INC Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 09:29AM | MWI Vet Beats on Both Lines Zacks |
| 08-Nov-12 10:08AM | On The Fly: Analyst Initiation Summary theflyonthewall.com |
| 01:23AM | Coverage initiated on Abaxis by Stifel Nicolaus Briefing.com |
| 07-Nov-12 08:00AM | Abaxis, Inc. to Present at the Stephens Fall Investment Conference PR Newswire |
| 06-Nov-12 08:00AM | Abaxis, Inc. to Present at the Lazard Capital Markets 9th Annual Healthcare Conference PR Newswire |
| 01-Nov-12 06:07AM | ABAXIS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits EDGAR Online |
| 31-Oct-12 05:00AM | Abaxis Announces Exclusive Distribution Agreement with Abbott PR Newswire |
| 26-Oct-12 03:57PM | ABAXIS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online |
| 10:59AM | Mixed 2Q for Abaxis Zacks |
| 25-Oct-12 03:18PM | Abaxis Hits Estimates in Solid Quarter at Motley Fool |
| 24-Oct-12 12:32PM | Healthcare Stocks, Including Gilead, Making Big Moves on October 24, 2012 at Investopedia -5.40% |
| 09:49AM | New Star Analyst Rankings for ABAXIS, Inc. StarMine |
| 06:02AM | ABAXIS INC Files SEC form 8-K, Other Events EDGAR Online |
| 23-Oct-12 04:02PM | ABAXIS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online |
|
|
| Abaxis, Inc. develops, manufactures, markets, and sells portable blood analysis systems for use in human or veterinary patient-care setting to provide blood constituent measurements for clinicians worldwide. The company offers point-of-care blood chemistry analyzer, which consists of a compact portable analyzer and a series of single-use plastic discs, called reagent discs, containing all the chemicals required to perform a panel of up to 14 tests on human patients and 13 tests on veterinary patients. It markets the blood analysis systems under the Piccolo Xpress, Piccolo Classic, VetScan VS2, and VetScan Classic names. The company also provides VetScan HM5, VetScan HM2, VetScan HMII, and VetScan HMT hematology instruments, as well as reagent kits for veterinary applications. In addition, it offers VetScan VSpro, which assists in the diagnosis and evaluation of suspected bleeding disorders, toxicity/poisoning, evaluation of disseminated intravascular coagulation, hepatic disease, monitoring therapy, and the progression of disease states; VetScan VSpro fibrinogen test to provide in-vitro determination of fibrinogen levels in equine platelet poor plasma from a citrated stabilized whole blood sample; and i-STAT 1 that delivers blood gas, electrolyte, basic blood chemistry, and hematology results. Further, the company provides Canine Heartworm rapid test to detect dirofilaria immitis in canine whole blood, serum, or plasma; Canine Parvovirus rapid test to detect canine parvovirus antigen in feces; VetScan Giardia rapid test to detect giardiasis, a gastrointestinal infection caused by the protozoan parasite Giardia; and Canine Lyme rapid test to detect Borrelia burgdorferi in canine whole blood, serum, or plasma. Additionally, it offers veterinary reference laboratory diagnostic and consulting services. The company sells its products through direct sales force and independent distributors. Abaxis, Inc. was founded in 1989 and is headquartered in Union City, California. |
|
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| Henkel Achim | Managing Director-Europe | May 07 | Sale | 44.07 | 5,000 | 220,370 | 21,200 | May 09 03:45 PM | | Henkel Achim | Managing Director-Europe | May 03 | Option Exercise | 0.00 | 3,000 | 0 | 26,200 | May 06 08:28 PM | | WOOD DONALD PETER | Chief Operations Officer | May 03 | Option Exercise | 0.00 | 3,750 | 0 | 31,455 | May 06 08:27 PM | | OSTOICH VLADIMIR | VP of Govt Affairs & Pac Rim | May 03 | Option Exercise | 0.00 | 3,750 | 0 | 389,744 | May 06 08:27 PM | | INES ALBERTO SANTA | CFO and VP of Finance | May 03 | Option Exercise | 0.00 | 3,750 | 0 | 57,812 | May 06 08:26 PM | | Mulroy Martin | Chief Commercial Officer | May 03 | Option Exercise | 0.00 | 3,750 | 0 | 32,086 | May 06 08:26 PM | | ARON KENNETH | Chief Technology Officer | May 03 | Option Exercise | 0.00 | 3,750 | 0 | 72,187 | May 06 08:25 PM | | SEVERSON CLINTON | President,CEO & Board Chairman | May 03 | Option Exercise | 0.00 | 8,250 | 0 | 574,971 | May 06 08:24 PM | | Henkel Achim | Managing Director-Europe | May 02 | Option Exercise | 0.00 | 2,000 | 0 | 23,200 | May 06 08:28 PM | | WOOD DONALD PETER | Chief Operations Officer | May 02 | Option Exercise | 0.00 | 2,500 | 0 | 29,006 | May 06 08:27 PM | | OSTOICH VLADIMIR | VP of Govt Affairs & Pac Rim | May 02 | Option Exercise | 0.00 | 2,500 | 0 | 385,994 | May 06 08:27 PM | | INES ALBERTO SANTA | CFO and VP of Finance | May 02 | Option Exercise | 0.00 | 2,500 | 0 | 55,367 | May 06 08:26 PM | | Mulroy Martin | Chief Commercial Officer | May 02 | Option Exercise | 0.00 | 2,500 | 0 | 29,641 | May 06 08:26 PM | | ARON KENNETH | Chief Technology Officer | May 02 | Option Exercise | 0.00 | 2,500 | 0 | 69,742 | May 06 08:25 PM | | SEVERSON CLINTON | President,CEO & Board Chairman | May 02 | Option Exercise | 0.00 | 5,500 | 0 | 569,591 | May 06 08:24 PM | | Henkel Achim | Managing Director-Europe | May 01 | Option Exercise | 0.00 | 3,500 | 0 | 21,200 | May 02 07:08 PM | | WOOD DONALD PETER | Chief Operations Officer | May 01 | Option Exercise | 0.00 | 17,500 | 0 | 33,083 | May 02 07:07 PM | | Mulroy Martin | Chief Commercial Officer | May 01 | Option Exercise | 0.00 | 17,500 | 0 | 33,857 | May 02 07:05 PM | | INES ALBERTO SANTA | CFO and VP of Finance | May 01 | Option Exercise | 0.00 | 17,500 | 0 | 61,999 | May 02 07:03 PM | | ARON KENNETH | Chief Technology Officer | May 01 | Option Exercise | 0.00 | 17,500 | 0 | 76,374 | May 02 07:02 PM | | OSTOICH VLADIMIR | VP of Govt Affairs & Pac Rim | May 01 | Option Exercise | 0.00 | 17,500 | 0 | 390,071 | May 02 07:01 PM | | SEVERSON CLINTON | President,CEO & Board Chairman | May 01 | Option Exercise | 0.00 | 38,500 | 0 | 582,524 | May 02 06:59 PM | | SINGH PRITHIPAL | Director | Apr 30 | Option Exercise | 0.00 | 4,500 | 0 | 33,500 | May 01 08:52 PM | | EVENHUIS HENK | Director | Apr 30 | Option Exercise | 0.00 | 4,500 | 0 | 14,900 | May 01 08:51 PM | | CASEY MICHAEL D | Director | Apr 30 | Option Exercise | 0.00 | 4,500 | 0 | 9,200 | May 01 08:50 PM | | BASTIANI RICHARD | Director | Apr 30 | Option Exercise | 0.00 | 4,500 | 0 | 49,400 | May 01 08:48 PM | | ALTMAN VERNON E | Director | Apr 30 | Option Exercise | 0.00 | 4,500 | 0 | 7,000 | May 01 08:47 PM | | Henkel Achim | Managing Director-Europe | Apr 30 | Option Exercise | 0.00 | 450 | 0 | 17,700 | May 02 07:08 PM | | WOOD DONALD PETER | Chief Operations Officer | Apr 30 | Option Exercise | 0.00 | 525 | 0 | 15,781 | May 02 07:07 PM | | Mulroy Martin | Chief Commercial Officer | Apr 30 | Option Exercise | 0.00 | 525 | 0 | 16,555 | May 02 07:05 PM | | INES ALBERTO SANTA | CFO and VP of Finance | Apr 30 | Option Exercise | 0.00 | 525 | 0 | 44,773 | May 02 07:03 PM | | ARON KENNETH | Chief Technology Officer | Apr 30 | Option Exercise | 0.00 | 525 | 0 | 59,148 | May 02 07:02 PM | | OSTOICH VLADIMIR | VP of Govt Affairs & Pac Rim | Apr 30 | Option Exercise | 0.00 | 525 | 0 | 372,571 | May 02 07:01 PM | | SEVERSON CLINTON | President,CEO & Board Chairman | Apr 30 | Option Exercise | 0.00 | 1,150 | 0 | 544,024 | May 02 06:59 PM | | Henkel Achim | Managing Director-Europe | Apr 29 | Option Exercise | 0.00 | 2,250 | 0 | 17,250 | May 01 09:03 PM | | WOOD DONALD PETER | Chief Operations Officer | Apr 29 | Option Exercise | 0.00 | 2,625 | 0 | 16,237 | May 01 09:02 PM | | Mulroy Martin | Chief Commercial Officer | Apr 29 | Option Exercise | 0.00 | 2,625 | 0 | 17,011 | May 01 09:00 PM | | INES ALBERTO SANTA | CFO and VP of Finance | Apr 29 | Option Exercise | 0.00 | 2,625 | 0 | 45,480 | May 01 08:59 PM | | ARON KENNETH | Chief Technology Officer | Apr 29 | Option Exercise | 0.00 | 2,625 | 0 | 59,948 | May 01 08:58 PM | | SEVERSON CLINTON | President,CEO & Board Chairman | Apr 29 | Option Exercise | 0.00 | 5,750 | 0 | 545,035 | May 01 08:56 PM | | SEVERSON CLINTON | President,CEO & Board Chairman | Mar 08 | Sale | 43.81 | 10,000 | 438,141 | 539,313 | Mar 11 03:04 PM | | Henkel Achim | Managing Director-Europe | Mar 01 | Sale | 42.85 | 1,000 | 42,850 | 15,000 | Mar 07 11:57 AM | | Henkel Achim | Managing Director-Europe | Feb 27 | Sale | 42.50 | 1,000 | 42,500 | 16,000 | Mar 06 02:30 PM | | Mulroy Martin | Chief Commercial Officer | Feb 26 | Sale | 41.84 | 12,000 | 502,121 | 14,402 | Feb 27 03:07 PM | | EVENHUIS HENK | Director | Feb 22 | Option Exercise | 17.25 | 4,000 | 69,000 | 14,400 | Feb 26 12:53 PM | | Henkel Achim | Managing Director-Europe | Feb 22 | Sale | 43.15 | 1,000 | 43,150 | 17,000 | Feb 28 12:41 PM | | EVENHUIS HENK | Director | Feb 22 | Sale | 43.25 | 4,000 | 173,000 | 10,400 | Feb 26 12:53 PM | | Henkel Achim | Managing Director-Europe | Feb 19 | Sale | 43.60 | 1,000 | 43,600 | 18,000 | Feb 25 11:42 AM | | Henkel Achim | Managing Director-Europe | Feb 15 | Sale | 43.65 | 1,000 | 43,650 | 19,000 | Feb 25 11:42 AM | | WOOD DONALD PETER | Chief Operations Officer | Feb 12 | Sale | 43.00 | 1,893 | 81,399 | 13,612 | Feb 12 06:32 PM | | WOOD DONALD PETER | Chief Operations Officer | Feb 08 | Sale | 43.62 | 5,244 | 228,758 | 15,505 | Feb 12 06:32 PM | | SINGH PRITHIPAL | Director | Feb 07 | Sale | 43.50 | 4,400 | 191,400 | 29,000 | Feb 08 11:24 AM | | SINGH PRITHIPAL | Director | Feb 06 | Option Exercise | 18.98 | 4,000 | 75,920 | 37,400 | Feb 08 11:24 AM | | INES ALBERTO SANTA | CFO and VP of Finance | Feb 06 | Sale | 43.90 | 6,555 | 287,765 | 45,410 | Feb 07 03:47 PM | | SINGH PRITHIPAL | Director | Feb 06 | Sale | 43.41 | 4,000 | 173,627 | 33,400 | Feb 08 11:24 AM | | ARON KENNETH | Chief Technology Officer | Feb 05 | Option Exercise | 21.65 | 4,500 | 97,425 | 62,345 | Feb 06 03:57 PM | | INES ALBERTO SANTA | CFO and VP of Finance | Feb 05 | Sale | 44.25 | 10,877 | 481,272 | 51,965 | Feb 07 03:47 PM | | ARON KENNETH | Chief Technology Officer | Feb 05 | Sale | 44.18 | 4,500 | 198,788 | 57,845 | Feb 06 03:57 PM | | ARON KENNETH | Chief Technology Officer | Feb 04 | Option Exercise | 21.65 | 35,500 | 768,575 | 93,345 | Feb 06 03:57 PM | | Mulroy Martin | Chief Commercial Officer | Feb 04 | Sale | 43.97 | 12,000 | 527,584 | 26,402 | Feb 06 04:00 PM | | ARON KENNETH | Chief Technology Officer | Feb 04 | Sale | 44.13 | 35,500 | 1,566,562 | 57,845 | Feb 06 03:57 PM | | INES ALBERTO SANTA | CFO and VP of Finance | Feb 04 | Sale | 43.98 | 25,000 | 1,099,624 | 62,842 | Feb 04 07:37 PM | | INES ALBERTO SANTA | CFO and VP of Finance | Jan 31 | Option Exercise | 3.85 | 25,000 | 96,250 | 87,842 | Feb 04 07:37 PM | | BASTIANI RICHARD | Director | Dec 11 | Option Exercise | 13.28 | 8,000 | 106,200 | 44,900 | Dec 12 11:32 AM | | BASTIANI RICHARD | Director | Dec 10 | Sale | 38.11 | 10,000 | 381,054 | 36,900 | Dec 12 11:32 AM | | EVENHUIS HENK | Director | Dec 07 | Option Exercise | 12.90 | 4,000 | 51,600 | 15,400 | Dec 11 04:38 PM | | SEVERSON CLINTON | President,CEO & Board Chairman | Dec 07 | Option Exercise | 21.65 | 33,100 | 716,615 | 582,318 | Dec 11 04:30 PM | | EVENHUIS HENK | Director | Dec 07 | Sale | 38.02 | 5,000 | 190,105 | 10,400 | Dec 11 04:38 PM | | OSTOICH VLADIMIR | VP of Govt Affairs & Pac Rim | Dec 07 | Sale | 38.00 | 5,000 | 190,000 | 369,038 | Dec 11 04:35 PM | | SEVERSON CLINTON | President,CEO & Board Chairman | Dec 07 | Sale | 38.36 | 1,835 | 70,396 | 549,218 | Dec 11 04:33 PM | | SEVERSON CLINTON | President,CEO & Board Chairman | Dec 07 | Sale | 38.22 | 12,955 | 495,141 | 551,053 | Dec 11 04:32 PM | | SEVERSON CLINTON | President,CEO & Board Chairman | Dec 07 | Sale | 37.96 | 18,310 | 695,100 | 564,008 | Dec 11 04:30 PM | | SEVERSON CLINTON | President,CEO & Board Chairman | Dec 03 | Option Exercise | 21.65 | 231 | 5,001 | 549,449 | Dec 05 06:54 PM | | SEVERSON CLINTON | President,CEO & Board Chairman | Dec 03 | Sale | 37.92 | 231 | 8,760 | 549,218 | Dec 05 06:54 PM | | SEVERSON CLINTON | President,CEO & Board Chairman | Nov 30 | Option Exercise | 21.65 | 13,969 | 302,429 | 563,187 | Dec 04 08:15 PM | | SEVERSON CLINTON | President,CEO & Board Chairman | Nov 30 | Sale | 37.81 | 13,969 | 528,136 | 549,218 | Dec 04 08:15 PM | | SEVERSON CLINTON | President,CEO & Board Chairman | Nov 29 | Option Exercise | 21.65 | 2,700 | 58,455 | 572,918 | Dec 03 07:38 PM | | OSTOICH VLADIMIR | VP of Govt Affairs & Pac Rim | Nov 29 | Sale | 37.00 | 19,428 | 718,836 | 374,038 | Nov 30 09:22 PM | | SEVERSON CLINTON | President,CEO & Board Chairman | Nov 29 | Sale | 37.80 | 2,700 | 102,048 | 570,218 | Dec 03 07:38 PM | | OSTOICH VLADIMIR | VP of Govt Affairs & Pac Rim | Nov 28 | Sale | 37.00 | 5,572 | 206,164 | 393,466 | Nov 30 09:22 PM | | BASTIANI RICHARD | Director | Nov 23 | Sale | 36.60 | 5,000 | 182,990 | 46,900 | Nov 27 05:04 PM | | Mulroy Martin | Chief Commercial Officer | Nov 06 | Sale | 37.79 | 10,292 | 388,937 | 28,058 | Nov 06 07:40 PM | | OSTOICH VLADIMIR | VP of Govt Affairs & Pac Rim | Sep 05 | Sale | 38.21 | 5,257 | 200,867 | 399,038 | Sep 14 05:44 PM | | Henkel Achim | Managing Director-Europe | Sep 04 | Sale | 37.85 | 1,000 | 37,850 | 20,000 | Sep 05 10:26 AM | | Henkel Achim | Managing Director-Europe | Aug 29 | Sale | 38.35 | 1,000 | 38,350 | 21,000 | Sep 05 10:06 AM | | INES ALBERTO SANTA | CFO and VP of Finance | Aug 28 | Sale | 38.50 | 12,690 | 488,565 | 62,776 | Aug 28 07:59 PM | | Henkel Achim | Managing Director-Europe | Aug 28 | Sale | 38.50 | 1,000 | 38,500 | 22,000 | Sep 04 04:44 PM | | Henkel Achim | Managing Director-Europe | Aug 27 | Sale | 38.10 | 1,628 | 62,021 | 24,500 | Aug 30 06:38 PM | | Henkel Achim | Managing Director-Europe | Aug 24 | Sale | 38.50 | 16 | 616 | 26,128 | Aug 29 12:55 PM | | HANLON BRENTON | VP-Sales & Marketing,Medical | Aug 22 | Sale | 38.78 | 3,000 | 116,330 | 0 | Aug 23 05:33 PM | | Henkel Achim | Managing Director-Europe | Aug 21 | Sale | 39.57 | 1,356 | 53,651 | 26,144 | Aug 24 06:35 PM | | INES ALBERTO SANTA | CFO and VP of Finance | Aug 21 | Sale | 39.00 | 7,488 | 292,032 | 75,466 | Aug 22 05:27 PM | | Henkel Achim | Managing Director-Europe | Aug 20 | Sale | 39.00 | 1,000 | 39,000 | 27,500 | Aug 24 06:35 PM | | INES ALBERTO SANTA | CFO and VP of Finance | Aug 20 | Sale | 39.00 | 5,163 | 201,357 | 82,954 | Aug 22 05:27 PM | | Henkel Achim | Managing Director-Europe | Aug 17 | Sale | 39.50 | 1,000 | 39,500 | 27,000 | Sep 04 04:40 PM | | Henkel Achim | Managing Director-Europe | Aug 16 | Sale | 38.25 | 500 | 19,125 | 28,000 | Sep 04 04:40 PM | | Henkel Achim | Managing Director-Europe | Aug 15 | Sale | 38.00 | 589 | 22,382 | 28,500 | Aug 24 06:34 PM | | Henkel Achim | Managing Director-Europe | Aug 07 | Sale | 37.80 | 411 | 15,536 | 29,089 | Aug 24 06:33 PM | | WOOD DONALD PETER | Chief Operations Officer | Jun 07 | Sale | 31.92 | 6,000 | 191,490 | 20,749 | Jun 08 08:33 PM |
|
|
|
|
|
|
